Target intelligence / Profile preview

Mucin layer of the ocular surface

Molecular classification
Specialized protective glycoprotein layer, composed of secreted (e.g., MUC5AC, MUC7) and membrane-associated mucins (e.g., MUC1, MUC4, MUC16)
01

Overview

The mucin layer of the ocular surface is a composite structure formed by high molecular weight glycoproteins (mucins) secreted by goblet cells and expressed on epithelial membranes (membrane-associated mucins). This layer is essential for tear film stability, lubrication, epithelial protection, debris/pathogen clearance, and minimizing evaporation. It prevents direct pathogenic binding and reduces friction during blinking by making the ocular surface highly hydrophilic and forming a barrier known as the glycocalyx. Major ocular surface mucins include secreted mucins (e.g., MUC5AC) and membrane-associated mucins (e.g., MUC1, MUC4, MUC16). Alteration in the mucin layer composition or structure underlies several ocular surface disorders, principally dry eye disease and infection susceptibility[2][3][7][8].

Other names
mucus layer of the tear filmocular surface mucin layertear film mucus layer
02

Mechanism of action

Drugs targeting mucin function modulate secretion or enhance integrity of the mucin layer (e.g., stimulating goblet cell secretion, supporting mucin glycosylation)

03

Biological functions

Lubrication of the ocular surface to reduce friction during blinkingMaintenance of epithelial barrier functionFacilitation of tear film stability and wettabilityClearance and trapping of debris, allergens, and pathogens (e.g., as “counter-receptors”)Defense against microbial invasion (some mucins have intrinsic antimicrobial activity)
04

Disease associations

Dry eye disease (altered quantity or quality of mucins is a hallmark)Ocular surface infections (deficient barrier predisposes to infection)Allergic conjunctivitis (asthma/allergy can affect mucin expression)Autoimmune conditions impacting lacrimal or goblet cell function
05

Safety considerations

Excessive mucin could obscure vision; disruption (deficiency) leads to dry eye, increased friction, infection risk, and impaired barrierRestoring mucin secretion is challenging due to complexity of epithelial and goblet cell biology
06

Interacting drugs

secretagogues

1 more in the full profile.

07

Biomarkers

Decreased tear film mucin content (notably MUC5AC) is a biomarker for dry eye diagnosis and severityGoblet cell counts and mucin immunostaining are used experimentally

Beyond the preview

Go deeper on Mucin layer of the ocular surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucin layer of the ocular surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call